Staff profile - Torie Foletta
Dr Torie Foletta
|Faculty or Division:||Faculty of Health|
|Department:||School of Exercise & Nut. Sci.|
|Campus:||Melbourne Burwood Campus|
|Phone:||+61 3 92446527 +61 3 92446527|
- Doctor of Philosophy, Australian National University, 1996
Australian Physiological Society
Australian Society for Medical Research
Dr Foletta is a regular reviewer for Metabolism, Clinical and Experimental, Molecular and Cellular Endocrinology, and Nutrition and Metabolism
Supervises 1 PhD student
Co-supervises 2 PhD students
Conferences and seminars
Foletta VC, McGee SL, Russell, AP. NDRG2, a putative tumour suppressor, increases ROS production and alters oxidative metabolism following its suppression in muscle cells. Oral Presentation. AussieMit 2012, Melbourne, 2012.
Foletta VC, Brown EL, Russell AP. Suppression of NDRG2, a novel PGC-1??? target gene, contributes to the metabolic profile and protein synthesis rates of skeletal muscle cells. Oral presentation. AuPS/ASB/PSNZ Meeting, Sydney, 2012.
Foletta VC, McGee SL, Brown EL, Russell AP. NDRG2, a new effector of PGC-1 function in the control of skeletal muscle mass and metabolism.
Invited Speaker. Exercise, Muscle & Metabolism, Melbourne, 2011.
Foletta VC, Russell AP. NDRG2, a novel player in the control of skeletal muscle mass? Oral presentation. AuPS/ASB Meeting, Adelaide, 2010.
Foletta VC, Cameron-Smith D, Walder K, Russell A. N-myc downstream-regulated gene 2 interacts with atrogin-1. A novel role for NDRG2 in skeletal muscle atrophy?
Oral presentation. Gage Muscle Conference, Canberra, ACT, 2010.
Awards and prizes
Fellows’ Award for Research Excellence, National Institutes of Health (NIH)
Fogarty Visiting Fellows’ Award, National Institutes of Health (NIH)
Dr Foletta is interested in characterizing specific molecular factors connecting skeletal muscle growth and metabolism. She uses a variety of molecular and cell biological techniques, genomics, proteomics and bioinformatics to obtain overviews of the molecules and signaling pathways involved in healthy and diseased states of skeletal muscle. Some of her current research projects involve the molecules NDRG2, PGC-1, ERRalpha, and the E3 ligases, atrogin-1/MAFbx and MuRF1.